Literature DB >> 1652157

Factor XI activation in a revised model of blood coagulation.

D Gailani1, G J Broze.   

Abstract

Coagulation factor XI is activated in vitro by factor XIIa in the presence of high molecular weight kininogen (HMWK) and a negatively charged surface. Factor XII deficiency is not associated with bleeding, which suggests that another mechanism for factor XI activation exists in vivo. A revised model of coagulation is proposed in which factor XI is activated by thrombin. In the absence of cofactors, thrombin is more effective (kcat/Km = 1.6 x 10(5)) than factor XIIa (1.7 x 10(4)) in activating factor XI. Dextran sulfate enhances activation of factor XI by thrombin 2000-fold; part of this effect is due to autoactivation of factor XI by activated factor XI.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652157     DOI: 10.1126/science.1652157

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  131 in total

1.  The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

Authors:  R L Nachman
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

2.  Blood coagulation dynamics under the conditions of Hageman factor deficiency: a mathematical model.

Authors:  I F Obraztsov; V M Kuz'min; M A Khanin
Journal:  Dokl Biochem Biophys       Date:  2002 Sep-Oct       Impact factor: 0.788

Review 3.  Hageman factor, platelets and polyphosphates: early history and recent connection.

Authors:  J Caen; Q Wu
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

4.  Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.

Authors:  Joanna Luszczak; Anetta Undas; Matthew Gissel; Maria Olszowska; Saulius Butenas
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

5.  Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models.

Authors:  J-S Bae; W Lee; A R Rezaie
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

6.  Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.

Authors:  Mariola M Marcinkiewicz; Dipali Sinha; Peter N Walsh
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

7.  Crystallization and preliminary crystallographic characterization of three peptidic inhibitors in complex with α-thrombin.

Authors:  Ana Carvalho Figueiredo; Cristina C Clement; Manfred Philipp; Pedro José Barbosa Pereira
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-12-21

8.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Authors:  Yuichi Kamikubo; G Loredana Mendolicchio; Antonella Zampolli; Patrizia Marchese; Andrea S Rothmeier; Jennifer Nagrampa Orje; Andrew J Gale; Sriram Krishnaswamy; András Gruber; Henrik Østergaard; Lars C Petersen; Wolfram Ruf; Zaverio M Ruggeri
Journal:  Blood       Date:  2017-07-20       Impact factor: 22.113

9.  Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.

Authors:  Likui Yang; Mao-fu Sun; David Gailani; Alireza R Rezaie
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

10.  An insertion mutation of the bovine Fii gene is responsible for factor XI deficiency in Japanese black cattle.

Authors:  Masaki Kunieda; Takehito Tsuji; Abdol Rahim Abbasi; Maryam Khalaj; Miho Ikeda; Keiko Miyadera; Hiroyuki Ogawa; Tetsuo Kunieda
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.